CYTARABINE SANDOZ 50 mg/ml, solution for injection bottle, 40 ml
Active ingredients: Cytarabine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottle, 40 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CYTARABINE SANDOZ 50 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 40 ml
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Mar 2008
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69140809CIP75714081CIP133400957140816Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CYTARABINEsolution | 50 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.